Your browser doesn't support javascript.
loading
Measurement of SARS-CoV-2 Antibody Titers Improves the Prediction Accuracy of COVID-19 Maximum Severity by Machine Learning in Non-Vaccinated Patients.
Kurano, Makoto; Ohmiya, Hiroko; Kishi, Yoshiro; Okada, Jun; Nakano, Yuki; Yokoyama, Rin; Qian, Chungen; Xia, Fuzhen; He, Fan; Zheng, Liang; Yu, Yi; Jubishi, Daisuke; Okamoto, Koh; Moriya, Kyoji; Kodama, Tatsuhiko; Yatomi, Yutaka.
Afiliación
  • Kurano M; Department of Clinical Laboratory, The University of Tokyo Hospital, Tokyo, Japan.
  • Ohmiya H; Department of Clinical Laboratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Kishi Y; Business Planning Department, Sales & Marketing Division, Medical & Biological Laboratories Co., Ltd, Tokyo, Japan.
  • Okada J; Business Planning Department, Sales & Marketing Division, Medical & Biological Laboratories Co., Ltd, Tokyo, Japan.
  • Nakano Y; Business Planning Department, Sales & Marketing Division, Medical & Biological Laboratories Co., Ltd, Tokyo, Japan.
  • Yokoyama R; Department of Clinical Laboratory, The University of Tokyo Hospital, Tokyo, Japan.
  • Qian C; Department of Clinical Laboratory, The University of Tokyo Hospital, Tokyo, Japan.
  • Xia F; The Key Laboratory for Biomedical Photonics of Ministry of Education at Wuhan National Laboratory for Optoelectronics - Hubei Bioinformatics & Molecular Imaging Key Laboratory, Systems Biology Theme, Department of Biomedical Engineering, College of Life Science and Technology, Huazhong Universit
  • He F; Reagent R&D Center, Shenzhen YHLO Biotech Co., Ltd, Shenzhen, China.
  • Zheng L; Reagent R&D Center, Shenzhen YHLO Biotech Co., Ltd, Shenzhen, China.
  • Yu Y; Reagent R&D Center, Shenzhen YHLO Biotech Co., Ltd, Shenzhen, China.
  • Jubishi D; Reagent R&D Center, Shenzhen YHLO Biotech Co., Ltd, Shenzhen, China.
  • Okamoto K; Department of Infection Control and Prevention, The University of Tokyo, Tokyo, Japan.
  • Moriya K; Department of Infection Control and Prevention, The University of Tokyo, Tokyo, Japan.
  • Kodama T; Department of Infection Control and Prevention, The University of Tokyo, Tokyo, Japan.
  • Yatomi Y; Laboratory for Systems Biology and Medicine, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
Front Immunol ; 13: 811952, 2022.
Article en En | MEDLINE | ID: mdl-35126396
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Índice de Severidad de la Enfermedad / Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 / Vacilación a la Vacunación / Anticuerpos Antivirales Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Índice de Severidad de la Enfermedad / Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 / Vacilación a la Vacunación / Anticuerpos Antivirales Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Suiza